Ventyx Biosciences, Inc. (VTYX) DCF Valuation

Ventyx Biosciences, Inc. (VTYX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Ventyx Biosciences, Inc. (VTYX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of Ventyx Biosciences, Inc. (VTYX) with our user-friendly DCF Calculator! Enter your projections for growth, margins, and costs to calculate the intrinsic value of Ventyx Biosciences, Inc. (VTYX) and refine your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 .0 -67.1 -108.0 -208.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 4.2 7.1 .0 .5 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.2 -7.1 -67.1 -108.4 -208.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .3 .2 286.7 356.6 252.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .4 1.1 4.7 6.4 5.8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.3 -.3 -.5 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.3 -7.1 -62.8 -108.0 -208.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .2 .7 -59.5 -106.0 -209.2 -5.8 .0 .0 .0 .0
WACC, % 6.04 6.04 6.01 6.03 6.04 6.03 6.03 6.03 6.03 6.03
PV UFCF
SUM PV UFCF -5.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -5
Net Debt -39
Equity Value 34
Diluted Shares Outstanding, MM 59
Equity Value Per Share 0.57

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Ventyx Biosciences, Inc. (VTYX) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life VTYX Financials: Pre-filled historical and projected data for Ventyx Biosciences, Inc. (VTYX).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Ventyx’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Ventyx’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Download the Template: Obtain and open the Excel file featuring Ventyx Biosciences, Inc.'s (VTYX) preloaded data.
  • 2. Modify Assumptions: Adjust critical inputs such as growth projections, WACC, and capital expenditures.
  • 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation results.
  • 5. Present with Assurance: Share professional valuation insights to back your strategic decisions.

Why Choose This Calculator for Ventyx Biosciences, Inc. (VTYX)?

  • Designed for Industry Experts: A sophisticated tool utilized by biotech analysts, CFOs, and investment consultants.
  • Comprehensive Data: Ventyx’s historical and projected financials are preloaded for enhanced precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Detailed, step-by-step instructions make the process straightforward.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for assessing investments in biotech companies.
  • Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Financial Consultants: Deliver precise valuation insights for Ventyx Biosciences, Inc. (VTYX) to clients.
  • Academic Professionals: Utilize real-world data for teaching and practicing financial analysis in biotechnology.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Ventyx Biosciences, Inc. (VTYX) are appraised in the market.

What the Template Contains

  • Historical Data: Includes Ventyx Biosciences’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Ventyx Biosciences’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Ventyx Biosciences’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.